Three Former Executives for Magellan Diagnostics Sentenced for False Statements and FDCA Violations

BOSTON – The former CEO, COO and Director of Quality Assurance and Regulatory Affairs for Magellan Diagnostics, Inc. (Magellan), a medical device company headquartered in Billerica, Mass., have been sentenced in federal court in Boston for concealing a device malfunction that produced inaccurately low lead test results for thousands of children and other patients. Amy Winslow, 54, of Needham, Mass., was sentenced on Oct. 27, 2025 by U.S. Senior District Court Judge Patti B. Saris to one year of home detention. Winslow was also ordered to pay a $10,000 fine. In March 2025, Winslow pleaded guilty to one felony count of introduction of misbranded medical devices into interstate commerce. Hossein Maleknia, 66, of Bonita Springs, Fla., was sentenced by Judge Saris on Oct. 30, 2025 to nine months of home detention. Maleknia was also ordered to pay a $20,000 fine. In March 2025, Maleknia pleaded guilty to two felony counts of introduction of misbranded medical devices into interstate commerce. On Nov. 21, 2025, Reba Daoust, 69, of Amesbury, Mass., was sentenced by Judge Saris to one year of probation, with the first six months to be served in home detention. Daoust was also ordered to pay a $600 fine. In March 2025, Daoust pleaded guilty to one felony count of making false statements.

Read more on www.justice.gov